MyHeritage Releases AI Record Finder™ and AI Biographer™ — Two Groundbreaking Features That Transform Genealogy Using Artificial Intelligence
MyHeritage, the leading global family history service, announced today the release of two groundbreaking features that mark the next frontier in family history research: AI Record Finder™ and AI Biographer™. AI Record Finder™ revolutionizes genealogy like ChatGPT revolutionized searching the internet: it is an interactive, intelligent, free-text chat to help the user locate relevant historical records about a person of interest in MyHeritage’s vast database of 20 billion records. AI Biographer™ automatically compiles a rich narrative about an individual’s life using information from historical records that match the person, creating a Wikipedia-like biography about anyone. Narratives are enriched with relevant historical context using AI and are easy to share. MyHeritage is the only service to offer such groundbreaking features for family history, and the first to leverage conversational AI for searching historical records. The two features are integrated, allowing users to generate an AI Biography™ for individuals they find using AI Record Finder™. AI Biographies™ may also be generated directly for individuals in family trees on MyHeritage.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231226134311/en/
MyHeritage Releases AI Record Finder™ and AI Biographer™ (Graphic: Business Wire)
AI Record Finder™
Until now, searching for historical records on online genealogy platforms like MyHeritage has been very similar to using a regular internet search engine. One entered names and other terms into dedicated fields in a search form, and the search engine returned a large number of search results. Then, it was necessary to comb through the results to discover relevant information. AI Record Finder™ transforms this experience by enabling users to converse with an AI assistant in a chat to quickly find records about their ancestors, relatives, or other deceased individuals. Users can still use the traditional search engine on MyHeritage, but AI Record Finder™ adds an additional chat mode that increases the chances that users may be able to find elusive records they have never found before, thanks to the power of AI.
The chat is like an interview with a friendly concierge that the user can converse with in one of two modes: casual or formal. AI Record Finder™ processes the information the user enters, and understands what additional details are necessary to help narrow down the search results. It guides the user by asking the relevant questions according to the context and information provided by the user, to find the most relevant records about the person the user is searching for. Once located, the records can be reviewed and the details saved to the user’s family tree. AI Record Finder™ includes a seamless user interface, where historical records that are found appear directly within the chat.
AI Biographer™
AI Biographer™ creates a rich Wikipedia-like biography summarizing a person’s life. This is especially useful for creating biographies about the billions of individuals who were not famous, and therefore do not appear in Wikipedia. An AI Biography™ can be created from historical records found via AI Record Finder™ and for deceased individuals within a user’s family tree on MyHeritage. AI Biographer™ utilizes MyHeritage’s acclaimed matching technologies to curate historical records and family tree profiles that pertain to the selected individual. All information from the pertinent records is then compiled into an biography that is enriched with photos and scanned documents, and in some cases, additional information from the web. The resulting biography includes the person’s immediate family, describes the main events of their life, and includes rich historical context and the origins of their surname. Each biography is a unique narrative that can be shared with family and friends, and saved for posterity. Facts listed in AI Biographies™ include footnotes and source citations, and link to the records from which they were obtained. Any inconsistencies within the information listed are noted. AI Biographies™ are saved as PDF files that are emailed to the user.
When created from the user’s family tree, an AI Biography™ is added to the family tree as a media item and tagged with the individual’s name, so that it is accessible through the MyHeritage mobile app and Family Tree Builder desktop software. The biography is included whenever the family tree is exported in GEDCOM format, ensuring that the enriched biographical information remains an integral part of the family tree. Biographies can easily be regenerated whenever new information becomes available. Additional entry points for generating an AI Biography™ such as from MyHeritage’s traditional form-based search engine, and from family tree profile pages, will be added soon.
“We’re constantly pushing the boundaries of genealogy to reinvent the way people can discover their family history as we implement a bold vision for genealogy in the 21st century,” said Gilad Japhet, Founder and CEO of MyHeritage. “AI Record Finder™ is a disruptive feature that simplifies the way people can find information about their ancestors by making the search easier and more intuitive. AI Biographer™ curates the details about a person’s life into a compelling story. Not all our ancestors were famous, but they all deserve to be remembered! Together, these cutting-edge features strengthen MyHeritage’s position as the industry leader for innovative genealogy and continue our mission to make family history easier, more accessible, and more fun for everyone.”
AI Record Finder™ and AI Biographer™ both use automated third-party technology powered by OpenAI.
Availability, Cost, and Language Support
AI Record Finder™ and AI Biographer™ are currently accessible from desktop and mobile web browsers. Support for both features on the MyHeritage mobile app will be added soon.
AI Record Finder™ is free for limited use. To submit an unlimited number of chat messages, and to view and save historical records to the family tree, a Data or Complete subscription is required. Users can create a few AI Biographies™ for free. Beyond that, additional use of AI Biographer™ requires a Complete subscription.
AI Record Finder™ and AI Biographer™ are initially available in English and will support additional languages in the near future. It is possible to converse with AI Record Finder™ in multiple languages, but at launch, it responds in English only.
About MyHeritage
MyHeritage is the leading global discovery platform for family history. With billions of historical records and family tree profiles, and with sophisticated matching technologies, MyHeritage gives users the joy of discovering their past and empowering their future. MyHeritage is the most popular family history service and DNA test in Europe, and is trusted by millions of users worldwide. Since 2020, MyHeritage is home to the world’s most advanced AI technologies for animating, repairing, enhancing, and colorizing historical photos. www.myheritage.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231226134311/en/
Contact information
MyHeritage
Sarah Vanunu
Director of Public Relations
Phone: 917-725-5018
Email: pr@myheritage.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CORRECTING and REPLACING PHOTO Decode the Future of AI and Customer Experience at Elevate'25 Digital Innovation Summit18.9.2025 21:23:00 EEST | Press release
Please replace the photo with the accompanying corrected photo. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918928987/en/ Gain insight and advice from firms at the frontier of AI-powered, mobile-first customer experiences. The release reads: DECODE THE FUTURE OF AI AND CUSTOMER EXPERIENCE AT ELEVATE'25 DIGITAL INNOVATION SUMMIT With keynotes from Google Cloud and an independent research firm, Elevate’25 will provide actionable strategies to harness the power of AI and create exceptional experiences for today's mobile-first consumer As unprecedented advancements in AI reshape consumer behavior, digital innovation summit Elevate'25 opened for general registration today. Sponsored by Airship, the exclusive, one-day event is designed to equip business leaders with proven strategies to harness artificial intelligence and mobile-first technology for a decisive competitive advantage. Taking place on October 15, 2025, at the i
Sai Life Sciences Opens Dedicated Facility for Veterinary APIs in Bidar, India18.9.2025 19:22:00 EEST | Press release
Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the opening of Unit VI, a dedicated facility for Veterinary Active Pharmaceutical Ingredient (API) production, in Bidar, India. Located alongside Unit IV, the company’s flagship API manufacturing site, Unit VI has been established exclusively for veterinary APIs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918612071/en/ Sai Life Sciences’ Veterinary APIs Unit in Bidar, India. The new facility is designed to meet the highest standards of safety, sustainability, and regulatory compliance, ensuring the production of high-quality APIs for veterinary applications. With this expansion, Sai Life Sciences aims to provide efficient and scalable manufacturing solutions to leading global animal health companies. Making the announcement, Krishna Kanumuri, CEO & Managing Direct
Celltrion Announces Commercial Availability of Omlyclo™ Across Europe at EADV 202518.9.2025 18:45:00 EEST | Press release
Celltrion, Inc. today showcased its longstanding commitment to expanding its biosimilar portfolio in the field of immuno-dermatology by attending the 2025 European Academy of Dermatology and Venereology (EADV) Congress, held 17-20 September in Paris, France. Following the European Commission (EC) approval of Omlyclo™, the first and only omalizumab biosimilar in Europe in May 2024, Omlyclo™ will be commercially available starting in Norway, with subsequent rollouts in European countries. As part of Celltrion’s mission to advance knowledge and understanding in dermatology, especially in chronic spontaneous urticaria (CSU), the company hosted satellite symposium presenting the results of the global Phase III clinical trial of Omlyclo™. The global Phase III clinical trial involved 619 patients with CSU, following them up to week 40. Patients were randomized to receive 300 mg or 150 mg of Omlyclo™, or reference product, every 4 weeks. Starting from week 12, patients who received Omlyclo™ we
Setting the Standard: AMRA Medical Recognized as one of TIME Magazine’s ‘World’s Top HealthTech Companies’18.9.2025 17:40:00 EEST | Press release
AMRA Medical is proud to share its inclusion in the World’s Top HealthTech Companies list, published today by TIME in collaboration with Statista. This recognition positions AMRA among an elite group of global innovators that are leading healthcare transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918372780/en/ AMRA Medical Recognized as one of TIME Magazine’s ‘World’s Top HealthTech Companies’ The selection, which comes just one week after celebrating AMRA’s 15 years of progress and innovation within the body composition space, highlights AMRA’s long-standing commitment to becoming a global leader in health informatics. By delivering detailed, reproducible insights within fat distribution and muscle composition, AMRA’s MRI-based technology is helping clinicians, researchers, and healthcare organizations unlock new levels of understanding across the metabolic and musculoskeletal sectors. “Being recognized by
illumynt, a CNE Direct Company, Is Pleased to Announce the Promotion of Jörg Herbarth to Chief Executive Officer (CEO)18.9.2025 17:30:00 EEST | Press release
illumynt, a CNE Direct company, is pleased to announce the promotion of Jörg Herbarth to Chief Executive Officer (CEO). Jörg has been a key member of illumynt’s executive leadership team since joining in June 2022, most recently serving as Chief Operating Officer. In his new role as CEO, Jörg will spearhead illumynt’s mission to become the number one provider of AI- and data-centric IT Asset Disposition (ITAD) solutions worldwide. Paul Knight, illumynt’s current CEO, will transition to the role of Founder & Chairman. In this capacity, Paul will continue to support the executive team with strategic guidance, while Jörg assumes full leadership of day-to-day operations and global expansion initiatives. Mr. Knight had come out of retirement a year ago to undertake some new initiatives and advance the company's strategic direction. With some necessary changes having taken place- he is thrilled to facilitate this transition to a reduced role again. Under Jörg’s leadership, illumynt will cont
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom